Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Nearly 1.5 million people die from tuberculosis every year, even though most cases can be cured with routine antibiotic treatments. One country’s fight to get the ancient scourge under control has an unlikely hero: a simple diagnostic test.
Researchers will test four experimental vaccines in a region in South Africa where one in five adults is infected with HIV.
A microfluidic chip could measure effectiveness of patient treatments in resource-poor countries.
A technique that alters T cells has been shown to reduce the amount of virus in infected people.
A simple microfluidics chip could improve health care in poor countries by making rapid diagnostic testing a reality.
Research offers insights into how some HIV-positive people are able to avoid the full-blown disease.
A new process could keep vaccines stable at tropical temperatures.
Longer-lasting drugs could mean more effective treatments.